title: The Potential Role of Edoxaban in Stroke Prevention Guidelines.
abstract: With the emergence of edoxaban, the oral factor Xa inhibitors now appear consolidated as the dominant class of novel oral anticoagulants (NOACs) for stroke prevention in non-valvular atrial fibrillation (AF). The oral factor Xa inhibitors do not require an adequate time in therapeutic range to be effective, presenting a potential advantage over the vitamin K antagonists (VKAs). Guidelines are changing to reflect the increased choice of anticoagulants and as clinicians move away from the VKAs towards the relative safety and efficacy of NOACs, they must consider which one offers the best therapy for their patient. The ENGAGE-AF study was the latest phase III trial to report on the safety and efficacy of a new factor Xa inhibitor relative to warfarin. Both edoxaban 60mg once daily, and edoxaban 30mg once daily were found to be non-inferior compared to warfarin for the prevention of ischaemic stroke and systemic embolism, being associated with significantly lower rates of major bleeding, intracranial haemorrhage and cardiovascular death. A two-tiered dosing option may present clinicians with a further element of choice for the individual patient.
authors.affiliation: Research Fellow.
authors.forename: Oliver
authors.initials: O
authors.lastname: Plunkett
authors.affiliation: Professor of Cardiovascular Medicine, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK.
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
keywords: Atrial fibrillation; CHA2DS2-VASc; ENGAGE-AF; NOAC; edoxaban; novel oral anticoagulants; stroke prevention
references.citation: Circulation. 2008 Nov 11;118(20):2029-37
references.pmid: 18955670
references.citation: Thromb Haemost. 2011 Jul;106(1):34-44
references.pmid: 21614409
references.citation: Thromb Haemost. 2013 Dec;110(6):1189-98
references.pmid: 24096615
references.citation: Cochrane Database Syst Rev. 2013 Aug 08;(8):CD008980
references.pmid: 23925867
references.citation: N Engl J Med. 2013 Nov 28;369(22):2093-104
references.pmid: 24251359
references.citation: Am J Cardiovasc Drugs. 2014 Apr;14 (2):111-27
references.pmid: 24504768
references.citation: Chest. 2012 Feb;141(2 Suppl):e531S-75S
references.pmid: 22315271
references.citation: Am Heart J. 2010 Oct;160(4):635-41
references.pmid: 20934556
references.citation: N Engl J Med. 2013 Oct 10;369(15):1406-15
references.pmid: 23991658
references.citation: Thromb Haemost. 2010 Sep;104(3):633-41
references.pmid: 20694273
references.citation: Chest. 2013 Nov;144(5):1437-8
references.pmid: 24189852
references.citation: Am J Cardiol. 2011 Jul 1;108(1):151-61
references.pmid: 21545990
references.citation: J Clin Pharmacol. 2010 Jul;50(7):743-53
references.pmid: 20081065
references.citation: Clin Cardiol. 2013 Feb;36(2):61-7
references.pmid: 23338902
references.citation: Drugs. 2011 Aug 20;71(12 ):1503-26
references.pmid: 21861537
references.citation: Thromb Haemost. 2013 Dec;110(6):1087-107
references.pmid: 24226379
references.citation: J Am Coll Cardiol. 2012 Aug 21;60(8):738-46
references.pmid: 22575324
references.citation: Can J Cardiol. 2012 Mar-Apr;28(2):125-36
references.pmid: 22433576
references.citation: N Engl J Med. 2009 Sep 17;361(12):1139-51
references.pmid: 19717844
references.citation: Lancet. 2014 Mar 15;383(9921):931-3
references.pmid: 24315725
references.citation: Circulation. 2012 Nov 13;126(20):2381-91
references.pmid: 23071159
references.citation: Lancet. 2014 Mar 15;383(9921):955-62
references.pmid: 24315724
references.citation: Am J Med. 2010 Jul;123(7):638-645.e4
references.pmid: 20609686
references.citation: Eur Heart J. 2012 Nov;33(21):2719-47
references.pmid: 22922413
references.citation: Chest. 2008 Jun;133(6 Suppl):160S-198S
references.pmid: 18574265
references.citation: Thromb Haemost. 2013 Apr;109(4):569-79
references.pmid: 23447024
references.citation: N Engl J Med. 2011 Sep 15;365(11):981-92
references.pmid: 21870978
references.citation: Thromb Haemost. 2011 Nov;106(5):968-77
references.pmid: 21901239
references.citation: Chest. 2013 Nov;144(5):1555-63
references.pmid: 23669885
references.citation: N Engl J Med. 2011 Sep 8;365(10):883-91
references.pmid: 21830957
references.citation: Angiology. 2012 Apr;63(3):164-70
references.pmid: 22007032
references.citation: Stroke. 2012 Dec;43(12):3442-53
references.pmid: 22858728